Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)
This study aims to understand more about Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP) in people aged 12 and older. It's an observational study, which means participants won't receive a new treatment or medication. Instead, researchers will gather information about how these conditions affect daily life and health. This will involve regular visits over six months to check symptoms, take blood samples, measure vital signs, and possibly wear a device to track light exposure. Participants will also keep a daily diary of their symptoms. The goal is to collect important data that could help improve our understanding and care for people with EPP and XLP.
Auf einen Blick
Worum geht es in dieser Studie?
This study focuses on two rare conditions called Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP). If you or someone you know has been diagnosed with one of these conditions, you might be familiar with the challenges they can bring, especially related to sun exposure. The main purpose of this research is to collect detailed information about how these conditions affect adults and teenagers in their everyday lives.
It's important to know that this isn't a study where you'll try a new medicine or treatment. Instead, it's an 'observational' study. This means the researchers will simply observe and record information about your condition as it is, without changing your current care. By carefully collecting these details from many people, scientists can gain a much clearer picture of EPP and XLP.
The information gathered will help doctors and researchers understand the conditions better, which could eventually lead to improved ways to diagnose, manage, and care for people living with EPP and XLP in the future. Your participation could make a real difference in advancing our knowledge.
Wichtige Erkenntnisse
- Study collects information on EPP/XLP in ages 12 and up.
- It's an observational study; no new treatments are given.
- Participation involves periodic visits and symptom diaries over 6 months.
- Helps researchers understand EPP/XLP better, potentially improving future care.
- Sie können jederzeit von der Studie zurücktreten.
Wer könnte berechtigt sein?
To join this study, you need to be at least 12 years old and have a confirmed diagnosis of EPP or XLP. This diagnosis might be based on genetic tests showing specific changes in your genes, or on blood tests that show high levels of a substance called PPIX, along with your symptoms and family history.
You should currently be experiencing symptoms of EPP or XLP. A key part of this is having a history of feeling a consistent, non-painful sensation within about 45 minutes of sun exposure, just before you experience more severe skin reactions. You also need to be willing to participate fully, which includes wearing a special device that measures light, keeping a daily diary of your symptoms, and covering certain areas of your skin when asked for specific tests.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Sind Sie 12 Jahre alt oder älter?
- Do you have a confirmed diagnosis of EPP or XLP?
- Are you currently experiencing symptoms related to EPP/XLP?
- Do you have a history of feeling early, mild symptoms before sun-related skin reactions?
- Are you willing to wear a light-measuring device and keep a daily symptom diary?
Was beinhaltet die Teilnahme?
If you decide to take part, the study will last for up to 6 months. After an initial screening, you'll have a first main visit (called Baseline Day 1). Over the next 24 weeks, you'll come back for follow-up visits every 4 weeks.
During these visits and at home, you'll be asked to do several things. This includes having standard checks like physical exams, measuring your blood pressure and heart rate (vital signs), and giving blood samples to check certain levels in your blood. You might also be asked to wear a device that measures the amount of light you're exposed to. A very important part of the study is keeping a daily diary to record your EPP/XLP-related symptoms. It's also possible you may need to keep certain skin areas covered before specific tests, as explained by the study team. You won't receive any new treatments as part of this study.
Potenzielle Risiken und Vorteile
Locations (19)
- Massachusetts General HospitalVerifizierte PostleitzahlBoston, Vereinigte Staaten· Rekrutierung
- Mount Sinai School of MedicineVerifizierte PostleitzahlNew York, Vereinigte Staaten· Rekrutierung
- Wake Forest University Baptist Health - Dept of GastroenterologyVerifizierte PostleitzahlWake Forest, United States· Rekrutierung
- Temple UniversityVerifizierte PostleitzahlPhiladelphia, Vereinigte Staaten· Noch nicht rekrutiert
- University of Texas Health - Ertan Digestive Disease CenterVerifizierte PostleitzahlHouston, Vereinigte Staaten· Rekrutierung
- UZ LeuvenVerifizierte PostleitzahlLeuven, Belgien· Noch nicht rekrutiert
- University of Alberta HospitalVerifizierte PostleitzahlEdmonton, Kanada· Noch nicht rekrutiert
- Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - AndreVerifizierte PostleitzahlBordeaux, Frankreich· Noch nicht rekrutiert
- AP-HP Hopital Bichat - Claude BernardVerifizierte PostleitzahlParis, Frankreich· Noch nicht rekrutiert
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MilanoVerifizierte PostleitzahlMailand, Italien· Noch nicht rekrutiert
- Azienda Ospedaliero-Universitaria di ModenaVerifizierte PostleitzahlModena, Italy· Noch nicht rekrutiert
- Haukeland University HospitalVerifizierte PostleitzahlBergen, Norway· Noch nicht rekrutiert
Häufige Fragen
What is an 'observational' study?
An observational study means researchers watch and collect information about your condition without giving you any new treatments or medicines. They just observe what is already happening.
Will I receive new medicine in this study?
No, this study is about collecting information only. You will not be given any new treatments or medications as part of your participation.
Wie lange muss ich an der Studie teilnehmen?
The study will last for up to 6 months for each person who takes part.
Welche Art von Tests werde ich haben?
You'll have physical exams, blood tests, your vital signs (like blood pressure) checked, and you'll complete a daily diary. You might also wear a device that measures light.
Kann ich die Studie verlassen, wenn ich meine Meinung ändere?
Yes, you can decide to leave the study at any time, for any reason. It will not affect your usual medical care.
Wie Sie mehr erfahren können
GondolaBio Inquiries
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.